CORDIS - Risultati della ricerca dell’UE
CORDIS

Bivalent hantavirus vaccine for europe: different approaches and evaluation in animal models

Obiettivo

Hantaviruses are health threatening infectious agents causing hemorrhagic fevers with renal syndrome in humans. In Europe, the hantaviruses Pamela and Do Brava have been identified as the main pathogens. There is an urgent need for a development of a bivalent vaccine protecting occupational risk groups and inhabitants of hyper endemic regions against infections by these two viruses.

Invito a presentare proposte

Data not available

Meccanismo di finanziamento

CSC - Cost-sharing contracts

Coordinatore

HUMBOLDT-UNIVERSITAET BERLIN
Contributo UE
Nessun dato
Indirizzo
Schumannstraße 20/21
10117 Berlin
Germania

Mostra sulla mappa

Costo totale
Nessun dato

Partecipanti (4)